Persistent inhibitory circuit defects and disrupted social behaviour following in utero exogenous cannabinoid exposure

Molecular Psychiatry

Volumn 22, Issue 1, 2017, Pages 56-67

  Vargish, G A ^a   Pelkey, K A ^a   Yuan, X ^a   Chittajallu, R ^a   Collins, D ^a   Fang, C ^a   McBain, C J ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; CANNABIS; CHOLECYSTOKININ; DRONABINOL; BENZOXAZINE DERIVATIVE; CANNABINOID; CANNABINOID RECEPTOR; ENDOCANNABINOID; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IMMUNOHISTOCHEMISTRY; INTERNEURON; LIMIT OF QUANTITATION; MALE; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; SOCIAL BEHAVIOR; ANIMAL; C57BL MOUSE; DRUG EFFECTS; EMBRYOLOGY; HIPPOCAMPUS; METABOLISM; NERVOUS SYSTEM; PRENATAL EXPOSURE;

ANIMALS; BENZOXAZINES; CANNABINOIDS; CANNABIS; CHOLECYSTOKININ; DRONABINOL; ENDOCANNABINOIDS; FEMALE; HIPPOCAMPUS; INTERNEURONS; MICE; MICE, INBRED C57BL; MORPHOLINES; NAPHTHALENES; NERVOUS SYSTEM; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTOR, CANNABINOID, CB1; RECEPTORS, CANNABINOID; SOCIAL BEHAVIOR;

EID: 84961233495     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2016.17     Document Type: Article

References (61)

1. National Survey on Drug Use and Health (U.S.), United States. Results from the National Survey on Drug Use and Health: National Findings. National Survey on Drug Use and Health Series. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies: Rockville, MD, 2003.
2. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 2003; 42: 327-360.
3. Pijlman FT, Rigter SM, Hoek J, Goldschmidt HM, Niesink RJ. Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops. Addict Biol 2005; 10: 171-180.
4. Mehmedic Z, Chandra S, Slade D, Denham H, Foster S, Patel AS et al. Potency trends of Delta9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J Forensic Sci 2010; 55: 1209-1217.
5. Hayatbakhsh MR, Flenady VJ, Gibbons KS, Kingsbury AM, Hurrion E, Mamun AA et al. Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res 2012; 71: 215-219.
6. Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 2000; 22: 325-336.
7. Goldschmidt L, Richardson GA, Willford JA, Severtson SG, Day NL. School achievement in 14-year-old youths prenatally exposed to marijuana. Neurotoxicol Teratol 2012; 34: 161-167.
8. Leech SL, Larkby CA, Day R, Day NL. Predictors and correlates of high levels of depression and anxiety symptoms among children at age 10. J Am Acad Child Adolesc Psychiatry 2006; 45: 223-230.
9. Noland JS, Singer LT, Short EJ, Minnes S, Arendt RE, Kirchner HL et al. Prenatal drug exposure and selective attention in preschoolers. Neurotoxicol Teratol 2005; 27: 429-438.
10. Howlett AC. The cannabinoid receptors. Prostaglandins Other Lipid Mediat 2002; 68-69: 619-631.
11. Berghuis P, Dobszay MB, Wang X, Spano S, Ledda F, Sousa KM et al. Endo-cannabinoids regulate interneuron migration and morphogenesis by transacti-vating the TrkB receptor. Proc Natl Acad Sci USA 2005; 102: 19115-19120.
12. Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, Urban GM et al. Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science 2007; 316: 1212-1216.
13. Mulder J, Aguado T, Keimpema E, Barabas K, Ballester Rosado CJ, Nguyen L et al. Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc Natl Acad Sci USA 2008; 105: 8760-8765.
14. Diaz-Alonso J, Aguado T, Wu CS, Palazuelos J, Hofmann C, Garcez P et al. The CB (1) cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axis. J Neurosci 2012; 32: 16651-16665.
15. Tortoriello G, Morris CV, Alpar A, Fuzik J, Shirran SL, Calvigioni D et al. Miswiring the brain: Delta9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway. EMBO J 2014; 33: 668-685.
16. Alpar A, Tortoriello G, Calvigioni D, Niphakis MJ, Milenkovic I, Bakker J et al. Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. Nat Commun 2014; 5: 4421.
17. Wu CS, Zhu J, Wager-Miller J, Wang S, O'Leary D, Monory K et al. Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections. Eur J Neurosci 2010; 32: 693-706.
18. de Salas-Quiroga A, Diaz-Alonso J, Garcia-Rincon D, Remmers F, Vega D, Gomez-Canas M et al. Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons. Proc Natl Acad Sci USA 2015; 112: 13693-13698.
19. Morozov YM, Freund TF. Post-natal development of type 1 cannabinoid receptor immunoreactivity in the rat hippocampus. Eur J Neurosci 2003; 18: 1213-1222.
20. Morozov YM, Torii M, Rakic P. Origin, early commitment, migratory routes, and destination of cannabinoid type 1 receptor-containing interneurons. Cereb Cortex 2009; 19(Suppl 1): i78-i89.
21. Antypa M, Faux C, Eichele G, Parnavelas JG, Andrews WD. Differential gene expression in migratory streams of cortical interneurons. Eur J Neurosci 2011; 34: 1584-1594.
22. Saez TM, Aronne MP, Caltana L, Brusco AH. Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55, 212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex. J Neurochem 2014; 129: 637-648.
23. Morozov YM, Freund TF. Postnatal development and migration of cholecystokinin-immunoreactive interneurons in rat hippocampus. Neuroscience 2003; 120: 923-939.
24. Nagode DA, Tang AH, Yang K, Alger BE. Optogenetic identification of an intrinsic cholinergically driven inhibitory oscillator sensitive to cannabinoids and opioids in hippocampal CA1. J Physiol 2014; 592(Pt 1): 103-123.
25. Sauer JF, Struber M, Bartos M. Impaired fast-spiking interneuron function in a genetic mouse model of depression. eLife 2015; 4: e04979.
26. Yang M, Silverman JL, Crawley JN. Automated three-chambered social approach task for mice. Curr Protoc Neurosci 2011; Chapter 8: Unit 8.26.
27. Mereu G, Fa M, Ferraro L, Cagiano R, Antonelli T, Tattoli M et al. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc Natl Acad Sci USA 2003; 100: 4915-4920.
28. Mato S, Chevaleyre V, Robbe D, Pazos A, Castillo PE, Manzoni OJ. A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity. Nat Neurosci 2004; 7: 585-586.
29. Chittajallu R, Craig MT, McFarland A, Yuan X, Gerfen S, Tricoire L et al. Dual origins of functionally distinct O-LM interneurons revealed by differential 5-HT(3 A)R expression. Nat Neurosci 2013; 16: 1598-1607.
30. Tricoire L, Pelkey KA, Erkkila BE, Jeffries BW, Yuan X, McBain CJ. A blueprint for the spatiotemporal origins of mouse hippocampal interneuron diversity. J Neurosci 2011; 31: 10948-10970.
31. Xu Q, Tam M, Anderson SA. Fate mapping Nkx2.1-lineage cells in the mouse telencephalon. J Comp Neurol 2008; 506: 16-29.
32. Lee S, Hjerling-Leffler J, Zagha E, Fishell G, Rudy B. The largest group of superficial neocortical GABAergic interneurons expresses ionotropic serotonin receptors. J Neurosci 2010; 30: 16796-16808.
33. Somogyi J, Baude A, Omori Y, Shimizu H, El Mestikawy S, Fukaya M et al. GABAergic basket cells expressing cholecystokinin contain vesicular glutamate transporter type 3 (VGLUT3) in their synaptic terminals in hippocampus and isocortex of the rat. Eur J Neurosci 2004; 19: 552-569.
34. Bezaire MJ, Soltesz I. Quantitative assessment of CA1 local circuits: knowledge base for interneuron-pyramidal cell connectivity. Hippocampus 2013; 23: 751-785.
35. Hill EL, Gallopin T, Ferezou I, Cauli B, Rossier J, Schweitzer P et al. Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. J Neurophysiol 2007; 97: 2580-2589.
36. Donato F, Rompani SB, Caroni P. Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning. Nature 2013; 504: 272-276.
37. Cope DW, Maccaferri G, Marton LF, Roberts JD, Cobden PM, Somogyi P. Cholecystokinin-immunopositive basket and Schaffer collateral-associated inter-neurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus. Neuroscience 2002; 109: 63-80.
38. Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E, Watanabe M et al. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 2006; 26: 2991-3001.
39. Pitler TA, Alger BE. Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism. Neuron 1994; 13: 1447-1455.
40. Wilson RI, Nicoll RA. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001; 410: 588-592.
41. Glickfeld LL, Scanziani M. Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci 2006; 9: 807-815.
42. Basu J, Srinivas KV, Cheung SK, Taniguchi H, Huang ZJ, Siegelbaum SA. A cortico-hippocampal learning rule shapes inhibitory microcircuit activity to enhance hippocampal information flow. Neuron 2013; 79: 1208-1221.
43. Neu A, Foldy C, Soltesz I. Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J Physiol 2007; 578(Pt 1): 233-247.
44. Kim J, Alger BE. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat Neurosci 2010; 13: 592-600.
45. Hefft S, Jonas P. Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse. Nat Neurosci 2005; 8: 1319-1328.
46. Foldy C, Malenka RC, Sudhof TC. Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron 2013; 78: 498-509.
47. Trezza V, Campolongo P, Cassano T, Macheda T, Dipasquale P, Carratu MR et al. Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats. Psycho-pharmacology (Berl) 2008; 198: 529-537.
48. Omiya Y, Uchigashima M, Konno K, Yamasaki M, Miyazaki T, Yoshida T et al. VGluT3-expressing CCK-positive basket cells construct invaginating synapses enriched with endocannabinoid signaling proteins in particular cortical and cortex-like amygdaloid regions of mouse brains. J Neurosci 2015; 35: 4215-4228.
49. Aguado T, Palazuelos J, Monory K, Stella N, Cravatt B, Lutz B et al. The endo-cannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J Neurosci 2006; 26: 1551-1561.
50. Keimpema E, Mackie K, Harkany T. Molecular model of cannabis sensitivity in developing neuronal circuits. Trends Pharmacol Sci 2011; 32: 551-561.
51. Shabani M, Hosseinmardi N, Haghani M, Shaibani V, Janahmadi M. Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring. Neuroscience 2011; 172: 139-152.
52. Campolongo P, Trezza V, Cassano T, Gaetani S, Morgese MG, Ubaldi M et al. Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neuro-transmission in rats. Addict Biol 2007; 12: 485-495.
53. Spano MS, Ellgren M, Wang X, Hurd YL. Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood. Biol Psychiatry 2007; 61: 554-563.
54. Maccarrone M, Guzman M, Mackie K, Doherty P, Harkany T. Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. Nat Rev Neurosci 2014; 15: 786-801.
55. Kehrer C, Maziashvili N, Dugladze T, Gloveli T. Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia. Front Mol Neurosci 2008; 1: 6.
56. Calfa G, Li W, Rutherford JM, Pozzo-Miller L. Excitation/Inhibition imbalance and impaired synaptic inhibition in hippocampal area CA3 of Mecp2 knockout mice. Hippocampus 2014; 25: 159-168.
57. Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O'Shea DJ et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011; 477: 171-178.
58. Ziburkus J, Cressman JR, Schiff SJ. Seizures as imbalanced up states: excitatory and inhibitory conductances during seizure-like events. J Neurophysiol 2013; 109: 1296-1306.
59. Cass DK, Flores-Barrera E, Thomases DR, Vital WF, Caballero A, Tseng KY. CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex. Mol Psychiatry 2014; 19: 536-543.
60. Lee SH, Soltesz I. Requirement for CB1 but not GABAB receptors in the chole-cystokinin mediated inhibition of GABA release from cholecystokinin expressing basket cells. J Physiol 2011; 589(Pt 4): 891-902.
61. Etherton M, Foldy C, Sharma M, Tabuchi K, Liu X, Shamloo M et al. Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. Proc Natl Acad Sci USA 2011; 108: 13764-13769.